| Name | Title | Contact Details |
|---|
BDA Partners is the global investment banking advisor for Asia. We are a premium provider of Asia-related advice to sophisticated clients globally, with over 20 years` experience advising on cross-border M&A, capital raising, and financial restructuring. We provide global reach with our teams in New York and London, and true regional depth through our seven Asian offices in Tokyo, Seoul, Shanghai, Hong Kong, Ho Chi Minh City, Singapore and Mumbai. BDA has deep expertise in the Chemicals, Consumer & Retail, Health, Industrials, Services and Technology sectors. We work relentlessly to earn our clients` trust by delivering insightful advice and outstanding outcomes. BDA carries out its US securities business through BDA Advisors Inc, a broker-dealer registered with the US Securities and Exchange Commission (SEC) and a member of FINRA and SIPC. BDA`s UK subsidiary is authorised and regulated by the Financial Conduct Authority. In Hong Kong, Business Development Asia Ltd. is licensed and regulated by the Securities & Futures Commission (SFC) to conduct Type 1 and Type 4 regulated activities to professional investors.
Launched in 2011, OMERS Ventures is the venture capital arm of OMERS, the pension plan for Ontario`s municipal employees. Over the last five years, OMERS Ventures has invested more than $340 million of capital in nearly 30 disruptive technology companies across North America, creating over 5,000 jobs, and attracting an additional $1.2 billion for our portfolio companies.
Smith Whiley and Company is a Hartford, CT-based company in the Financial Services sector.
iD Ventures America is a Santa Clara, CA-based company in the Financial Services sector.
NaviMed Capital is a Washington, DC-based private capital firm focused exclusively on the healthcare industry. NaviMed makes substantial investments in fast growing lower middle market healthcare businesses. The firm focus on healthcare services, healthcare IT, hospital products, and distribution businesses which are poised to benefit from the reform and technology innovation forces reshaping the healthcare industry. NaviMed targets profitable private companies with up to $10 million of EBITDA and double digit revenue growth. NaviMed seeks investments which can benefit from its deep industry expertise, broad relationship network and combined 50+ year track record of success as healthcare investors and operators. NaviMed`s senior investment team has a track record of value creation spanning dozens of investments and more than $6.5 billion of enterprise value created.